Immune Thrombocytopenia Secondary to COVID-19 Infection

Isr Med Assoc J. 2021 Jun;23(6):342-343.

Authors

Amram Kupietzky¹, Elchanan Parnasa², Matan Fischer², Rottem Kuint³, Murad Daana²

Affiliations

¹ Department of Surgery, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.
² Department of Internal Medicine, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.
³ Department of Pulmonary Medicine, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.

PMID: 34155845

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Autoantibodies / blood
COVID-19* / blood
COVID-19* / complications
COVID-19* / physiopathology
COVID-19* / therapy
Cardiolipins / immunology
Diagnosis, Differential
Humans
Hydrocortisone
Immunoglobulins, Intravenous / administration & dosage*
Immunologic Factors / administration & dosage
Male
Middle Aged
Patient Acuity
Platelet Count / methods*
Purpura, Thrombocytopenic, Idiopathic* / diagnosis
Purpura, Thrombocytopenic, Idiopathic* / etiology
Purpura, Thrombocytopenic, Idiopathic* / therapy
SARS-CoV-2 / isolation & purification
Treatment Outcome

Substances

Autoantibodies
Cardiolipins
Immunoglobulins, Intravenous
Immunologic Factors
Hydrocortisone